Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
Displaying 1 - 9 of 9 Clinical Trials
ID/Name Source Type
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
NCT02477800 clinicaltrials.gov Clinical Trial
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
NCT02484547 clinicaltrials.gov Clinical Trial
Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants
NCT02782975 clinicaltrials.gov Clinical Trial
Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
NCT01677572 clinicaltrials.gov Clinical Trial
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease
NCT03352557 clinicaltrials.gov Clinical Trial
Randomized, Double Blind, Placebo Controlled Prospective Study, to Evaluate the Effect of a Vegetal Oil in the Disease's Natural Evolution in Patients Diagnosed With Cognitive Impairment or Mild to Moderate Alzheimer Disease.
NCT02778581 clinicaltrials.gov Clinical Trial
Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease
NCT02434718 clinicaltrials.gov Clinical Trial
Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
NCT01397539 clinicaltrials.gov Clinical Trial
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
NCT03056729 clinicaltrials.gov Clinical Trial